A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle
1 other identifier
observational
148
2 countries
12
Brief Summary
Post Market clinical outcomes study to collect data on the short - and long-term outcomes for subjects who are undergoing or who have undergone the Subchondroplasty Procedure in the foot and/or ankle in a standard clinical setting. Outcomes to be assessed include pain medication usage, pain, function, activity levels and patient satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2017
Longer than P75 for all trials
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 21, 2017
CompletedStudy Start
First participant enrolled
March 10, 2017
CompletedFirst Posted
Study publicly available on registry
March 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 23, 2023
CompletedResults Posted
Study results publicly available
April 9, 2026
CompletedApril 9, 2026
January 1, 2024
6.5 years
February 21, 2017
January 15, 2026
March 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Foot Function Index-Revised (FFI-R) Short Form Score at 24 Months
Foot Function Index - Revised Short Form (FFI-R SF) subscale scores. Measures foot pain, disability, and activity limitation. Items scored 1-4 (1=best, 4=worst); 5=not applicable to the subject and does not indicate worse function. Subscales calculated from applicable items and converted to 0-100%. Higher=more pain/worse function.
24 months
Secondary Outcomes (15)
Pain and Functional Performance by the Numeric Pain Score (NPS) From Baseline at 6-weeks
6 weeks postoperative
Pain and Functional Performance at 6 Weeks by the Foot Function Index-Revised (FFI-R) Short Form
6 weeks postoperative
Pain and Functional Performance at 3 Months by the Foot Function Index-Revised (FFI-R) Short Form
3 Months postoperative
Pain and Functional Performance at 6 Months by the Foot Function Index-Revised (FFI-R) Short Form
6 Months postoperative
Pain and Functional Performance at 1 Year by the Foot Function Index-Revised (FFI-R) Short Form
1 Year postoperative
- +10 more secondary outcomes
Interventions
Filling of micro fractures or insufficiency fractures with a bone substitute material
Eligibility Criteria
Approximately 140 subjects, each with at least one bone marrow lesion (BML) in any of the bones of the foot and/or ankle who have elected to undergo or have undergone the Subchondroplasty (SCP) procedure will be enrolled in the study.
You may qualify if:
- Subject has at least one bone defect such as a bone marrow lesion (BML), cyst or stress fracture confirmed by diagnostic imaging
- Surgeon considers the patient appropriate for the SCP procedure
- Subject provides voluntary signature on the Institutional Review Board (IRB) approved Informed Consent
- Subject is at least 18 years of age
- Subject must be physically and mentally willing and able, in the Investigator's opinion at the time of enrollment, to complete outcome forms via the internet, telephone or regular mail
You may not qualify if:
- Subject is pregnant at the time of surgery
- Subject is incarcerated
- Subject is involved in active litigation related to the condition being treated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zimmer Biometlead
Study Sites (12)
OrthoArizona
Mesa, Arizona, 85206, United States
The CORE Institute
Sun City, Arizona, 85351, United States
OrthoNorcal
Capitola, California, 95010, United States
Eisenhower Desert Orthopedic Center
Rancho Mirage, California, 92270, United States
Stanford University Medical Center, Orthopedics
Redwood City, California, 94063, United States
University of California, Davis
Sacramento, California, 95817, United States
Capital Orthopaedics and Sports Medicine
Clive, Iowa, 50325, United States
Podiatry Center of the Lehigh Valley
Bethlehem, Pennsylvania, 18018, United States
Rothman Institute
Bryn Mawr, Pennsylvania, 19010, United States
Premier Orthopaedics & Sports Medicine
Exton, Pennsylvania, 19341, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
St. Paul's Hospital (Providence Health)
Vancouver, British Columbia, V6Z 1Y6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Annette Tieu, Clinical Research Specialist
- Organization
- Zimmer Biomet
Study Officials
- PRINCIPAL INVESTIGATOR
Robert B Anderson, MD
OrthoCarolina Research Institute, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 21, 2017
First Posted
March 22, 2017
Study Start
March 10, 2017
Primary Completion
August 23, 2023
Study Completion
August 23, 2023
Last Updated
April 9, 2026
Results First Posted
April 9, 2026
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share